114 results
Page 3 of 6
6-K/A
EX-99.5
zi9negfw m1iihwo1np4
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K
EX-99.2
9xscu9qr0i6r coyoj
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.5
0j3mdgbtjs 2v
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.2
b6wqe5 nb
5 Aug 21
Index to Unaudited Condensed Consolidated Financial Statements
6:04am
6-K
EX-99.1
ph1suq54n
27 Jul 21
Current report (foreign)
6:12am
6-K
EX-99.2
79fzxm yi3
1 Jun 21
ObsEva SA Announces that Shareholders Approved all Board Proposals at its
6:30am
6-K
EX-99.1
mrhaggxag6n4ppypm
20 May 21
ObsEva Announces Final Results from the Phase 3 PRIMROSE Program of
6:30am
6-K
EX-99.1
ea0 t9ik7yo7070a8
6 May 21
Index to Unaudited Condensed Consolidated Financial Statements
6:03am
6-K
EX-99.3
l0wge
6 May 21
Index to Unaudited Condensed Consolidated Financial Statements
6:03am
6-K
EX-99.2
svicjk dywis
6 May 21
Index to Unaudited Condensed Consolidated Financial Statements
6:03am
6-K
EX-99.1
4rbe9zue
31 Mar 21
Current report (foreign)
7:15am
6-K
EX-1.1
sp4l5549g66
5 Mar 21
Current report (foreign)
8:15am
424B5
4ar1fot8e2sas28qgiv
5 Mar 21
Prospectus supplement for primary offering
7:55am
6-K
EX-99.1
g3a wwk58c4
5 Mar 21
ObsEva Announces Year End 2020 Financial Results
7:21am
6-K
EX-99.2
m2ku7vc8y tzz08ydoyf
17 Feb 21
ObsEva to Present at the SVB Leerink 10th Annual Global Healthcare Conference
6:04am
6-K
EX-99.1
m73hgsvykpt8 j7bgbyj
10 Feb 21
ObsEva Provides Business Outlook for 2021
6:10am
6-K/A
EX-99.1
nq18az
19 Jan 21
Current report (foreign) (amended)
6:25am